First Major Survey of Multiple Sclerosis (MS) Nurses Highlights Significant Disparities in MS Nursing Across Europe
By Novartis, PRNEMonday, May 24, 2010
The Findings from MS-NEED (Multiple Sclerosis-Nurse Empowering EDucation): European Survey Highlights the Need to Define and Benchmark Healthcare Provision in MS Across Europe
BRUSSELS, May 26, 2010 - The first major survey of European Multiple Sclerosis (MS) nurses
revealed that nearly one in three nurses (31%) reported that standards of
MS care are not adequately maintained in their country. The results of
this survey will be presented for the first time on Friday 28 May, via a
live webcast at the European MS Platform (EMSP) Annual Congress in
Stuttgart, Germany.
The MS-NEED: European Survey polled 280 MS nurses in the Czech Republic,
Finland, Germany, Italy, Poland and the UK, and found considerable variations
in the availability of specialised training and education for MS nurses
across Europe that could potentially impact equality of care for people with
MS across Europe. Overall, one in five nurses reported that they have not
received adequate training and education to support them in their day-to-day
role.
Amy Perrin Ross, President of the International Organization of Multiple
Sclerosis Nurses (IOMSN) said, "The findings from MS-NEED: European Survey
show how far MS nurses have come in expanding their role but also identify
further areas for development. A benchmark and standard for training and
certification of MS nurses across Europe is needed to ensure equality of
health service provision and to improve the quality of life of MS patients
and their families."
The survey, conducted by the EMSP in cooperation with the IOMSN and
Rehabilitation in MS (RIMS), the European network of MS centres, also
highlighted variations in clinical practice, access to support services such
as rehabilitation, and participation in research.
"MS nurses provide critical information, support and advice to MS
patients and their families throughout the course of this chronic, disabling
disease. By providing this specialised, expert service they can make an
important impact on the overall quality of life of patients. It is therefore
important to recognise MS nursing as a speciality within Europe and to find a
way to unify, define and benchmark care provision to avoid geographical
inequalities in patient care" said Professor Hans-Peter Hartung (Professor
and Chairman, Dept. of Neurology Heinrich-Heine University, Germany).
Hear the results of MS-NEED: European Survey for the first time and the
EMSP, IOMSN and RIMS recommendations for action on a European and national
level by logging onto the MS-NEED: European Survey live, interactive webcast
on Friday, 28 May, at 12:30 CET using the information below:
Please click on the website link: www.emsp.org/ms-need/
The webcast provides you with a unique opportunity to learn about the
data and ask questions, in real-time, from leading global nurse thought
leaders.
What is MS?
Multiple Sclerosis (MS) is a complex, chronic, disabling disease. It
affects twice as many women as men, and is usually first diagnosed between
the ages of 20 and 40, at a critical stage in adult life with often
considerable family and work responsibilities. To date, no cure exists. It is
estimated that there are more than 500,000 people with MS in Europe.
European MS Platform (EMSP) represents their interests at the European
level, working with the European bodies on behalf of its 33 national member
organisations to achieve its goals of high quality & equitable treatment and
support for all citizens suffering from MS.
The MS-NEED: European Survey was conducted by Adelphi International
Research and was supported by an unrestricted educational grant from Novartis
Pharma AG.
For more information please contact: Christoph Thalheim, EMSP Secretary General, Tel: +32-2-305-8012, Mob: +32-485-47-99-86, Email:christoph.thalheim at emsp.org
Tags: belgium, Brussels, May 26, Novartis